Idarubicin

Tumori. 2002 Jan-Feb;88(1 Suppl 1):S73-4. doi: 10.1177/030089160208800122.
No abstract available

MeSH terms

  • Administration, Oral
  • Aged
  • Aged, 80 and over
  • Antibiotics, Antineoplastic / administration & dosage
  • Antibiotics, Antineoplastic / adverse effects
  • Antibiotics, Antineoplastic / pharmacology*
  • Breast Neoplasms / drug therapy*
  • Clinical Trials as Topic
  • Female
  • Humans
  • Idarubicin / administration & dosage
  • Idarubicin / adverse effects
  • Idarubicin / pharmacology*
  • Prognosis

Substances

  • Antibiotics, Antineoplastic
  • Idarubicin